Search research articles
Contact Us
Filters
Showing results (21-30 of 42) with videos related to
Page
of 5
Sort By:
Plos One
|
December 31, 2021
Transcriptomic profiling of adjuvant colorectal cancer identifies three key prognostic biological processes and a disease specific role for granzyme B
Anneleen Daemen, Akshata R Udyavar, Thomas Sandmann, et al.
The Journal of Molecular Diagnostics : JMD
|
September 5, 2017
High-Throughput and Sensitive Quantification of Circulating Tumor DNA by Microfluidic-Based Multiplex PCR and Next-Generation Sequencing
Yinghui Guan, Oleg Mayba, Thomas Sandmann, et al.
Nature Neuroscience
|
June 10, 2020
Alzheimer's-associated PLCγ2 is a signaling node required for both TREM2 function and the inflammatory response in human microglia
Benjamin J Andreone, Laralynne Przybyla, Ceyda Llapashtica, et al.
Nature Communications
|
October 29, 2013
Wnt secretion is required to maintain high levels of Wnt activity in colon cancer cells
Oksana Voloshanenko, Gerrit Erdmann, Taronish D Dubash, et al.
Acta Neuropathologica
|
September 6, 2013
Hypoxia and oxygenation induce a metabolic switch between pentose phosphate pathway and glycolysis in glioma stem-like cells
Annegret Kathagen, Alexander Schulte, Gerd Balcke, et al.
Neuro-Oncology
|
October 11, 2017
Radiologic progression of glioblastoma under therapy-an exploratory analysis of AVAglio
Martha Nowosielski, Benjamin M Ellingson, Olivier L Chinot, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 1, 2015
Patients With Proneural Glioblastoma May Derive Overall Survival Benefit From the Addition of Bevacizumab to First-Line Radiotherapy and Temozolomide: Retrospective Analysis of the AVAglio Trial
Thomas Sandmann, Richard Bourgon, Josep Garcia, et al.
Leukemia & Lymphoma
|
October 3, 2018
Obinutuzumab plus CHOP is effective and has a tolerable safety profile in previously untreated, advanced diffuse large B-cell lymphoma: the phase II GATHER study
Jeff P Sharman, Andres Forero-Torres, Luciano J Costa, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 6, 2016
Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase II Study of Onartuzumab Plus Bevacizumab Versus Placebo Plus Bevacizumab in Patients With Recurrent Glioblastoma: Efficacy, Safety, and Hepatocyte Growth Factor and O<sup>6</sup>-Methylguanine-DNA Methyltransferase Biomarker Analyses
Timothy Cloughesy, Gaetano Finocchiaro, Cristóbal Belda-Iniesta, et al.
Molecular Neurodegeneration
|
August 19, 2025
Early intervention anti-Aβ immunotherapy attenuates microglial activation without inducing exhaustion at residual plaques
Lis de Weerd, Selina Hummel, Stephan A Müller, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 42) with videos related to
Sort By:
Page
of 5
Plos One
|
December 31, 2021
Transcriptomic profiling of adjuvant colorectal cancer identifies three key prognostic biological processes and a disease specific role for granzyme B
Anneleen Daemen, Akshata R Udyavar, Thomas Sandmann, et al.
The Journal of Molecular Diagnostics : JMD
|
September 5, 2017
High-Throughput and Sensitive Quantification of Circulating Tumor DNA by Microfluidic-Based Multiplex PCR and Next-Generation Sequencing
Yinghui Guan, Oleg Mayba, Thomas Sandmann, et al.
Nature Neuroscience
|
June 10, 2020
Alzheimer's-associated PLCγ2 is a signaling node required for both TREM2 function and the inflammatory response in human microglia
Benjamin J Andreone, Laralynne Przybyla, Ceyda Llapashtica, et al.
Nature Communications
|
October 29, 2013
Wnt secretion is required to maintain high levels of Wnt activity in colon cancer cells
Oksana Voloshanenko, Gerrit Erdmann, Taronish D Dubash, et al.
Acta Neuropathologica
|
September 6, 2013
Hypoxia and oxygenation induce a metabolic switch between pentose phosphate pathway and glycolysis in glioma stem-like cells
Annegret Kathagen, Alexander Schulte, Gerd Balcke, et al.
Neuro-Oncology
|
October 11, 2017
Radiologic progression of glioblastoma under therapy-an exploratory analysis of AVAglio
Martha Nowosielski, Benjamin M Ellingson, Olivier L Chinot, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 1, 2015
Patients With Proneural Glioblastoma May Derive Overall Survival Benefit From the Addition of Bevacizumab to First-Line Radiotherapy and Temozolomide: Retrospective Analysis of the AVAglio Trial
Thomas Sandmann, Richard Bourgon, Josep Garcia, et al.
Leukemia & Lymphoma
|
October 3, 2018
Obinutuzumab plus CHOP is effective and has a tolerable safety profile in previously untreated, advanced diffuse large B-cell lymphoma: the phase II GATHER study
Jeff P Sharman, Andres Forero-Torres, Luciano J Costa, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 6, 2016
Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase II Study of Onartuzumab Plus Bevacizumab Versus Placebo Plus Bevacizumab in Patients With Recurrent Glioblastoma: Efficacy, Safety, and Hepatocyte Growth Factor and O<sup>6</sup>-Methylguanine-DNA Methyltransferase Biomarker Analyses
Timothy Cloughesy, Gaetano Finocchiaro, Cristóbal Belda-Iniesta, et al.
Molecular Neurodegeneration
|
August 19, 2025
Early intervention anti-Aβ immunotherapy attenuates microglial activation without inducing exhaustion at residual plaques
Lis de Weerd, Selina Hummel, Stephan A Müller, et al.
Page
of 5